Correlation Between Q2 Holdings and COSCIENS Biopharma

Can any of the company-specific risk be diversified away by investing in both Q2 Holdings and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q2 Holdings and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Q2 Holdings and COSCIENS Biopharma, you can compare the effects of market volatilities on Q2 Holdings and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q2 Holdings with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q2 Holdings and COSCIENS Biopharma.

Diversification Opportunities for Q2 Holdings and COSCIENS Biopharma

-0.15

Correlation Coefficient

Q2 Holdings  COSCIENS Biopharma

Good diversification

The 3 months correlation between QTWO and COSCIENS is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Q2 Holdings and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Q2 Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q2 Holdings are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Q2 Holdings i.e., Q2 Holdings and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Q2 Holdings and COSCIENS Biopharma

Given the investment horizon of 90 days Q2 Holdings is expected to under-perform the COSCIENS Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Q2 Holdings is 2.73 times less risky than COSCIENS Biopharma. The stock trades about -0.17 of its potential returns per unit of risk. The COSCIENS Biopharma is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  250.00  in COSCIENS Biopharma on December 20, 2024 and sell it today you would earn a total of  93.00  from holding COSCIENS Biopharma or generate 37.2% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Q2 Holdings  vs.  COSCIENS Biopharma

Q2 Holdings

Risk-Adjusted Performance

Very Weak

Over the last 90 days Q2 Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

COSCIENS Biopharma

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in COSCIENS Biopharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent fundamental indicators, COSCIENS Biopharma demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Q2 Holdings and COSCIENS Biopharma

The main advantage of trading using opposite Q2 Holdings and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q2 Holdings position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.

The idea behind Q2 Holdings and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.